早期口腔鳞癌切缘状态与局部复发:再切除结局分析
该回顾性研究分析352例cT1-2N0口腔鳞癌患者,按切缘状态分为初始阴性、再切除至阴性和阳性三组。结果显示再切除至阴性者3年局部复发率仍高于初始阴性者,阳性切缘复发风险最高。再切除至阴性不应等同于初始阴性切缘。
要点
- 再切除至阴性切缘的3年局部复发率高于初始阴性切缘。
- 阳性切缘局部复发风险显著高于初始阴性切缘。
- 再切除至阴性者与阳性切缘者的复发率无显著差异。
核心结论
- 再切除至阴性切缘不应在肿瘤学上等同于初始阴性切缘,因其3年局部复发率更高。
研究设计与样本
- 回顾性分析352例cT1-2N0口腔鳞状细胞癌患者,2005至2024年单中心数据。
- 按切缘状态分层:初始阴性325例、再切除至阴性20例、阳性7例。
主要发现
- 最常见亚部位为舌(60.2%),75.9%接受择区性颈清扫。
- 3年局部复发率:初始阴性10.5%,再切除至阴性35.0%,阳性42.9%。
- 阳性切缘对比初始阴性:HR 5.67(95%CI 1.74-18.61)。
- 再切除至阴性对比初始阴性:HR 3.32(95%CI 1.47-7.49)。
- 校正辅助治疗和切缘评估方法后,阳性aHR 8.32(95%CI 2.31-29.9),再切除至阴性aHR 3.82(95%CI 1.68-8.68)。
关键数值与推荐
- 阳性与再切除至阴性切缘之间局部复发率无显著差异(P = .374)。
- 辅助治疗呈保护趋势(aHR 0.53,95%CI 0.24-1.17,P = .117)。
- 5.7%患者初始阳性切缘经再切除至阴性;4.8%和22.7%分别接受辅助放化疗和放疗。
临床怎么用
- 对再切除至阴性切缘的早期口腔鳞癌患者,应视为局部复发高风险人群。
- 需加强随访或考虑辅助治疗,但辅助治疗获益趋势未达统计学显著。
局限性
- 回顾性单中心设计,再切除至阴性组和阳性组样本量小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the impact of surgical margin status and re-resection on local recurrence (LR) in early-stage oral cavity squamous cell carcinoma (OCSCC). STUDY DESIGN: Retrospective analysis of 352 patients with cT1-2N0 OCSCC. SETTING: Tertiary care center from 2005 to 2024. METHODS: Patients were stratified by margin status: initial negative (n = 325), re-resected to negative (RRN) (n = 20), and positive (n = 7). Initial margin status was determined intraoperatively with frozen sections using specimen-based or tumor bed-based sampling. Primary outcome was 3-year LR. Chi-square tests and Cox proportional hazards models evaluated differences across groups, accounting for potential confounders, for example, adjuvant treatment. RESULTS: The most common subsite was the tongue (60.2%). 75.9% underwent elective neck dissection. 5.7% had an initial positive margin RRN. 4.8% and 22.7% received adjuvant chemoradiotherapy and radiotherapy, respectively. LR rates were 10.5% for initial negative, 35.0% for RRN, and 42.9% for positive margins despite re-resection. Compared to patients with initial negative, those with positive (hazard ratio [HR] 5.67, 95% CI 1.74-18.61) and RRN (HR 3.32, 95% CI 1.47-7.49) margins showed higher rates of LR. There was no significant difference in LR rates between positive versus RRN margins (P = .374). After controlling for adjuvant therapy and margin assessment method, positive (aHR 8.32, 95% CI 2.31-29.9) and RRN (aHR 3.82, 95% CI 1.68-8.68) margins remained associated with higher LR. Adjuvant therapy trended toward a protective effect (aHR 0.53, 95% CI 0.24-1.17, P = .117). CONCLUSION: RRN margins should not be considered oncologically equivalent to initial negative margins, as demonstrated by higher 3-year LR rates.
引用
- Brown HJ, Wang NC, Alapati R, et al. Margin Status and Local Recurrence in Early-Stage Oral-Cavity Squamous Cell Carcinoma: Analysis of Reresection Outcomes. Otolaryngol Head Neck Surg. 2026. PMID: 42489355. doi:10.1002/ohn.70343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。